The FDA approved pembrolizumab for certain women with microsatellite instability-high or mismatch repair-deficient advanced endometrial cancer. The latest approval of pembrolizumab (Keytruda, Merck), ...

Eisai announced today the presentation of clinical research across its oncology portfolio and pipeline during the European ...

The approval was based on data from cohorts D and K of the phase 2 KEYNOTE-158 trial, which included patients with multiple types of advanced solid tumors. The Food and Drug Administration (FDA) has ...

Kirk Shepard, MD, chief medical officer, senior vice president, and head of Global Medical Affairs, Eisai, discusses findings of a study showcasing similar health-related quality of life (HRQOL) ...

November 3, 2009 (Chicago, Illinois) — Type I endometrial cancer patients, who normally have a good prognosis, occasionally succumb to their disease within 2 to 3 years. Investigators from the ...

The prognostic value of lymphadenectomy in the revised 2009 FIGO staging system for endometrial cancer: A multicenter study. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This ...

—These investigators compared criteria from the two commonly used pathologic risk classification systems for endometrial carcinoma, assessed their concordance with molecular subtypes, and evaluated ...

Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group Purpose: To validate the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA granted regular approval to the ...

A 13-yr-old female bengal tiger (Panthera tigris bengalensis) had been implanted subcutaneously three times at 2-yr intervals with melengestrol acetate, a progestin compound used as a contraceptive in ...